Development of target delivery system based on actinomycin class drugs and recombinant alpha-fetoprotein
Тип публикации: Journal Article
Дата публикации: 2017-03-01
scimago Q3
wos Q4
white level БС3
SJR: 0.223
CiteScore: 1.5
Impact factor: 0.7
ISSN: 16076729, 16083091
PubMed ID:
28510139
General Chemistry
Biochemistry
General Medicine
Biophysics
Краткое описание
A recombinant alpha-fetoprotein (rAFP) was obtained in the yeast P. pastoris system, and its functional activity was confirmed. A method for producing polymer particles loaded with dactinomycin was developed, and a conjugate of these nanoparticles with rAFP was synthesized. The efficiency of the obtained conjugate on the HeLa, SKOV3, and MG-63 tumor cells and the absence of toxicity on the normal cells was shown. Experiments in vivo demonstrated a significant increase in the antitumor efficacy of the conjugate at a lower general toxicity as compared to the commercially available dactinomycin.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.
Топ-30
Журналы
|
1
2
|
|
|
Fine Chemical Technologies
2 публикации, 25%
|
|
|
Biochemistry (Moscow)
2 публикации, 25%
|
|
|
Biotekhnologiya
1 публикация, 12.5%
|
|
|
Applied Biochemistry and Microbiology
1 публикация, 12.5%
|
|
|
Russian Journal of Biotherapy
1 публикация, 12.5%
|
|
|
1
2
|
Издатели
|
1
2
3
|
|
|
Pleiades Publishing
3 публикации, 37.5%
|
|
|
RTU MIREA
2 публикации, 25%
|
|
|
State Research Institute for Genetics and Selection of Industrial Microorganisms
1 публикация, 12.5%
|
|
|
Institute of Biochemistry
1 публикация, 12.5%
|
|
|
Publishing House ABV Press
1 публикация, 12.5%
|
|
|
1
2
3
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Войти с ORCID
Метрики
8
Всего цитирований:
8
Цитирований c 2025:
2
(25%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Nikolskaya E. D. et al. Development of target delivery system based on actinomycin class drugs and recombinant alpha-fetoprotein // Doklady Biochemistry and Biophysics. 2017. Vol. 473. No. 1. pp. 148-150.
ГОСТ со всеми авторами (до 50)
Скопировать
Nikolskaya E. D., Zhunina O. A., Yabbarov N. G., Shvets V. I., Krugliy B. I., Severin E. S. Development of target delivery system based on actinomycin class drugs and recombinant alpha-fetoprotein // Doklady Biochemistry and Biophysics. 2017. Vol. 473. No. 1. pp. 148-150.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1134/s1607672917020156
UR - https://doi.org/10.1134/s1607672917020156
TI - Development of target delivery system based on actinomycin class drugs and recombinant alpha-fetoprotein
T2 - Doklady Biochemistry and Biophysics
AU - Nikolskaya, E D
AU - Zhunina, O A
AU - Yabbarov, N G
AU - Shvets, V. I.
AU - Krugliy, B I
AU - Severin, E S.
PY - 2017
DA - 2017/03/01
PB - Pleiades Publishing
SP - 148-150
IS - 1
VL - 473
PMID - 28510139
SN - 1607-6729
SN - 1608-3091
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2017_Nikolskaya,
author = {E D Nikolskaya and O A Zhunina and N G Yabbarov and V. I. Shvets and B I Krugliy and E S. Severin},
title = {Development of target delivery system based on actinomycin class drugs and recombinant alpha-fetoprotein},
journal = {Doklady Biochemistry and Biophysics},
year = {2017},
volume = {473},
publisher = {Pleiades Publishing},
month = {mar},
url = {https://doi.org/10.1134/s1607672917020156},
number = {1},
pages = {148--150},
doi = {10.1134/s1607672917020156}
}
Цитировать
MLA
Скопировать
Nikolskaya, E. D., et al. “Development of target delivery system based on actinomycin class drugs and recombinant alpha-fetoprotein.” Doklady Biochemistry and Biophysics, vol. 473, no. 1, Mar. 2017, pp. 148-150. https://doi.org/10.1134/s1607672917020156.
Лаборатории
Ошибка в публикации?